These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 9424663)
1. [The incidence of the antiphospholipid syndrome in the clinical and biological manifestations of systemic lupus erythematosus]. Sánchez Rodríguez A; Martín Oterino JA; Fidalgo Fernández MA; Araoz Sánchez P; Alonso García P; Fernández Navarro P; Chimpén Ruiz V; Portugal Alvarez J Rev Clin Esp; 1997 Oct; 197(10):669-74. PubMed ID: 9424663 [TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
5. [Antiphospholipid syndrome and stroke]. Kitagawa Y Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672 [TBL] [Abstract][Full Text] [Related]
7. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations. Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986 [TBL] [Abstract][Full Text] [Related]
9. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489 [TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. Somers E; Magder LS; Petri M J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147 [TBL] [Abstract][Full Text] [Related]
11. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM; Shirokova IE; Lisitskaia TL Ter Arkh; 2006; 78(6):24-30. PubMed ID: 16881359 [TBL] [Abstract][Full Text] [Related]
12. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267 [TBL] [Abstract][Full Text] [Related]
13. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617 [TBL] [Abstract][Full Text] [Related]
14. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus. Sahin M; Duzgun N; Tunc SE; Tutkak H Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958 [TBL] [Abstract][Full Text] [Related]
16. Combined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis. Sanmarco M; Roll P; Gayet S; Oksman F; Johanet C; Escande A; Cohen JH; Chevailler A; Goetz J; Humbel RL; Sibilia J J Lab Clin Med; 2004 Sep; 144(3):141-7. PubMed ID: 15454883 [TBL] [Abstract][Full Text] [Related]
17. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome]. Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418 [TBL] [Abstract][Full Text] [Related]
18. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome]. Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118 [TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory. Mader R; Ziporen L; Mader R; Neumann L; Buskila D Clin Rheumatol; 2002 Sep; 21(5):386-90. PubMed ID: 12223987 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]